Outcomes4Me is a founding member of CancerX, an initiative of the Cancer Moonshot Learn more >

/ Uncategorized
Aromatase inhibitors (AIs). Such as anastrozole, exemestane, and letrozole. Selective estrogen receptor modulators (SERMs). Such...
Lisa Morere— MSN, APRN, ANP-BC—is the Clinical Lead at Outcomes4Me and is a board certified...
Recently An American Society of Clinical Oncology Journal (ASCO) released new guidance around recommendations for...
This year’s annual LBBC Conference on metastatic breast cancer (MBC) was a hybrid gathering of...
Last week breast oncologists and researchers from across the globe presented at the annual European...